Metsera's IPO raised $316.2 million, funding its obesity drug MET-097i, which shows promise with once-monthly dosing. Read ...

Guggenheim has initiated coverage of Metsera (MTSR) with a buy rating, citing the company's obesity drug candidates. Read ...

Guggenheim analyst sees significant upside in Metsera stock to $56. MTSR is working on both injectable and oral weight-loss ...

A live webcast of the presentation will be available on the Events page in the Investors & News section of the Metsera website at investors.metsera.com. A replay of the webcast will be available for ...

Evercore ISI analyst Umer Raffat initiated coverage of Metsera (MTSR) with an Outperform rating. Metsera has a full portfolio of GLP-1 ...

Metsera’s GLP-1 peptide has a long half-life, meaning it could be administered once a month. The company is ready to scale up ...

Michael Saylor buys 20,356 BTC for $1.99 billion, funding purchases with stock sales as shares drop 16%. Bitcoin's slump adds more risk.

The rate at which corporate and private institutions adopt the Bitcoin standard has surged extensively in the past year as ...

The Statistics Department said in the Malaysia Trade Statistics Review (MTSR) for 2024, the growth reflected the increasing demand for livestock and related products to meet domestic consumption ...

According to the Malaysia Trade Statistic Review 2023 (MTSR 2023) , the country’s total food trade surged by 31.8% or RM29bil in 2022, reaching a total value of RM120.2bil compared with the ...

Trading is due to start today on the Nasdaq under the MTSR ticker. Genetic medicines company Maze meanwhile sold 8.75 million shares at $16 apiece, with another 1.3 million on offer to the ...